BiotechTube
Home/Q32 Bio/Shelia Violette, Ph.D.
SV

Shelia Violette, Ph.D.

Founder, Chief Scientific Officer and President of Research

Q32 Bio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesAlopecia Areata

Q32 Bio Pipeline

DrugIndicationPhase
Bempikibart (ADX-914)Alopecia Areata (AA)Phase 2
ADX-096Complement-mediated diseasesDiscovery/Preclinical
C3d mAb fusionsComplement-mediated diseasesDiscovery/Preclinical
Complement-targeting nanobodiesComplement-mediated diseasesDiscovery/Preclinical

Leadership Team at Q32 Bio

JM
Jodie Morrison
Chief Executive Officer and Member of the Board of Directors
LK
Lee Kalowski, M.B.A.
President and Chief Financial Officer
View full Q32 Bio profile